# Efficacy and Safety of Finerenone in Heart Failure With Reduced Ejection Fraction

> **NCT05974566** · — · UNKNOWN · sponsor: **Chongqing Medical University** · enrollment: 60 (estimated)

## Conditions studied

- Heart Failure With Reduced Ejection Fraction
- Diabetes Mellitus
- Diabetic Nephropathies

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05974566
- **Lead sponsor:** Chongqing Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-08-01
- **Primary completion:** 2023-09-30
- **Final completion:** 2023-10-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2023-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05974566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05974566, "Efficacy and Safety of Finerenone in Heart Failure With Reduced Ejection Fraction". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05974566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*